Integrated Biopharma (INBP) Net Income towards Common Stockholders (2010 - 2026)
Integrated Biopharma (INBP) reported Net Income towards Common Stockholders of -$1.37 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$178,000 a year earlier.
Powered by 
Analysis
Integrated Biopharma (INBP) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Integrated Biopharma posted Net Income towards Common Stockholders of -$2.84 million.
- By fiscal year, Net Income towards Common Stockholders came in at $808,000 in FY2025 (+621.4%), $112,000 in FY2024, -$34,000 in FY2023 and $3.84 million in FY2022 (-52.1%).
- The fiscal Q4 2026 figure ranks as the lowest quarterly Net Income towards Common Stockholders since fiscal Q4 2012.
- The high point for year-over-year Net Income towards Common Stockholders in five years was fiscal Q4 2024 (growth of 570.0%); the low point was fiscal Q3 2023 (a decline of 98.0%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -$837,000 (Q3 2026), -$762,000 (Q2 2026) and $123,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Procter & Gamble | 336.76 Bn | 292.75 Bn | 10.28 Bn | 3.04 Bn |
| 2 | Colgate Palmolive | 67.18 Bn | 62.24 Bn | 3.30 Bn | 693.00 Mn |
| 3 | Estee Lauder Companies | 33.32 Bn | 21.40 Bn | 2.74 Bn | -116.00 Mn |
| 4 | Kenvue | 33.09 Bn | 28.70 Bn | 2.30 Bn | 456.00 Mn |
| 5 | Kimberly Clark | 31.38 Bn | 28.71 Bn | 1.60 Bn | 345.00 Mn |
| 6 | Church & Dwight | 22.37 Bn | 20.90 Bn | 693.90 Mn | 202.80 Mn |
| 7 | Clorox | 9.72 Bn | 8.16 Bn | 804.00 Mn | 163.00 Mn |
| 8 | e.l.f. Beauty | 6.17 Bn | 5.15 Bn | 398.84 Mn | 66.60 Mn |
| 9 | Reynolds Consumer Products | 4.71 Bn | 4.37 Bn | 245.00 Mn | 89.00 Mn |
| 10 | Integrated Biopharma | 5.59 Mn | -14.75 Mn | 28,000.00 | -1.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.37 Mn |
| Mar 31, 2026 | -837,000.00 |
| Dec 31, 2025 | -762,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Jun 30, 2025 | -178,000.00 |
| Mar 31, 2025 | 611,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Jun 30, 2024 | 268,000.00 |
| Mar 31, 2024 | 285,000.00 |
| Dec 31, 2023 | -382,000.00 |
| Sep 30, 2023 | -59,000.00 |
| Jun 30, 2023 | 40,000.00 |
| Mar 31, 2023 | 16,000.00 |
| Dec 31, 2022 | -55,000.00 |
| Sep 30, 2022 | -35,000.00 |
| Jun 30, 2022 | 1.49 Mn |
| Mar 31, 2022 | 797,000.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 516,000.00 |
API Access
Integrated Biopharma Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=INBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "INBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=INBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();